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Klaus Eichler*, Simon Wieser, Isabelle Rüthemann† and Urs Brügger†Abstract
Background: Micronutrient deficiency is a common public health problem in developing countries, especially for
infants and children in the first two years of life. As this is an important time window for child development,
micronutrient fortified complementary feeding after 6 months of age, for example with milk or cereals products, in
combination with continued breastfeeding, is recommended. The overall effect of this approach is unclear.
Methods: We performed a Systematic Review and Meta-analysis to assess the impact of micronutrient fortified milk
and cereal food on the health of infants and little children (aged 6 months to 5 years) compared to non-fortified
food. We reviewed randomized controlled trials using electronic databases (MEDLINE and Cochrane library searches
through FEB 2011), reference list screening and hand searches. Three reviewers assessed 1153 studies for eligibility
and extracted data. One reviewer assessed risk of bias using predefined forms.
Results: We included 18 trials in our analysis (n = 5’468 children; range of mean hemoglobin values: 9.0 to 12.6 g/
dl). Iron plus multi micronutrient fortification is more effective than single iron fortification for hematologic
outcomes. Compared to non-fortified food, iron multi micronutrient fortification increases hemoglobin levels by
0.87 g/dl (95%-CI: 0.57 to 1.16; 8 studies) and reduces risk of anemia by 57% (relative risk 0.43; 95%-CI 0.26 to 0.71;
absolute risk reduction 22%; number needed to treat 5 [95%-CI: 4 to 6]; 6 Studies). Compared to non-fortified food,
fortification increases serum levels of vitamin A but not of zinc. Information about functional health outcomes (e.g.
weight gain) and morbidity was scarce and evidence is inconclusive. Risk of bias is unclear due to underreporting,
but high quality studies lead to similar results in a sensitivity analysis.
Conclusions: Multi micronutrient fortified milk and cereal products can be an effective option to reduce anemia of
children up to three years of age in developing countries. On the basis of our data the evidence for functional
health outcomes is still inconclusive.
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Micronutrient (MN) deficiency is a common public
health problem, specifically for infants and children, in
many low and middle income countries. For example,
anemia (caused by iron deficiency) or increased infection
rates and mortality (exacerbated by vitamin A and zinc
deficiency) are serious threats for child development [1].
The first two years of life represent a narrow time win-
dow, which is of outstanding importance for child devel-
opment [2]. During this time period future growth and
vulnerable physiological capacities, such as cognitive* Correspondence: klaus.eichler@zhaw.ch
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reproduction in any medium, provided the orfunction and motor development, are determined. Even
with optimum breastfeeding, these steps depend on a an
adequate quantity and quality of complementary feeding,
leading to an adequate MN supply [2]. Negative health
consequences resulting from suboptimal feeding, such as
stunting (i.e. low height-for-age), are associated with
higher morbidity and decreased function in later life [3].
Several strategies have been shown to be effective in
resolving MN deficiencies for different target groups and
are proposed in recommendations and guidelines [4-6]:
Food based approaches (e.g. spreads to increase energy-
density and MN content of food; MN powders for home
fortification with sprinkles) and MN supplementation
(e.g. vitamin A capsules administered at defined intervals).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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flour or oil) is widely used to resolve MN deficiencies of
general populations.
Fortified complementary feeding after 6 months of
age, in combination with continued breastfeeding [7],
typically comprises milk or cereals products (e.g. por-
ridge or gruel) for infants. This type of food, however, is
often not covered by programs that provide fortified
staple food for the general population. Primary studies
have assessed the effects of fortified milk or cereals for
infants and children [8,9] and some countries, such as
Mexico, have introduced country wide food programs,
where fortified milk is one component [10]. However,
the overall evidence of the effect of fortified milk and
cereals on children has not been systematically assessed.
Thus, we performed a Systematic Review to specifically
assess the impact of micronutrient fortified milk and cereal
food on the health of infants and children compared to
non-fortified food in randomized controlled trials.
Methods
We performed our review in accordance with current
guidelines for performing [11,12] and reporting of sys-
tematic reviews [13] and established a scientific advisory
board (see Acknowledgments for participating experts).
A review study protocol was developed in advance,
though not published.
According to our research question we defined the fol-
lowing inclusion criteria: Population: Infants and chil-
dren from 6 months to 5 years of age. While our
primary focus was on age groups up to 2 years, we
decided to set an upper age limit at 5 years, in order not
to miss suitable studies with mixed age groups. Inter-
vention: Micronutrient fortified milk or cereal food.Table 1 Medline electronic search strategy
Step Search Medline 1 Search Medline 2
1 "Infant Formula"[MeSH]a
OR "Milk"[MeSH]
"economics"[MeSH
2 fortif*[TIAB]b "micronutrients"[M
3 1 AND 2 "Nutrition Disorder
4 "Cereals"[MeSH] 1 AND 2 AND3
5 fortif*[TIAB] "cost*"[TIAB]
6 4 AND 5 "micronutrients"[M
7 3 OR 6 "nutrition disorder
8 child*[TIAB] OR infant*[TIAB]
OR toddler*[TIAB]
5 AND 6 AND 7
9 7 AND 8 4 OR 8
Three Medline searches were performed and retrieved references were cumulated.
of micronutrient fortification as well, we included also search terms such as “cost” a
a MeSH: Medical Subject Heading.
bTIAB: Title/Abstract.Control intervention: Non-fortified food; additional
other nutritional approaches, if such approaches were
applied in the intervention and control group. Outcome:
At least one of the following health related outcomes:
surrogate measures (such as MN serum levels,
hematological parameters), functional outcome (e.g.
motor development), measures of morbidity (such as
disease rates) or mortality. Study designs: Randomized
controlled trials of any follow-up time.
We excluded studies with infants and toddlers younger
than 6 months [14] or applying infant formula [15],
studies addressing adolescents or adult women, inter-
ventions based on supplementation, home fortification,
bare food based approaches, fortification with compo-
nents other than micronutrients, and studies testing ab-
sorption of MN. A priori, we also excluded studies with
fortification of staple food as provided for larger popula-
tion groups to isolate the effect of fortified milk and
cereals.
We systematically searched for studies using electronic
databases (Medline [search strategy Table 1], Cochrane
library; from 1966 to February 2011; no language restric-
tion). As this review was part of a larger project, that
evaluates the economic effects of MN fortification as
well, we also included search terms such as “cost” and
“economics”. We screened reference lists of included
papers and contacted experts in the field for additional
references. In addition, we screened homepages of rele-
vant organizations (e.g. WHO, United Nations [World
Food Programme, Unicef, Millennium Development
Goals], The World Bank, Pakistan National Nutrition
Survey; International Clinical Epidemiology Network
[16]; Global Alliance for Improved Nutrition, GAIN
[17]; The Micronutrient Initiative [18]; Bill & MelindaSearch Medline 3
] nutrition disorders[MeSH]
eSH] child* OR infant* OR toddl*[TIAB]
s"[MeSH] "cost*"[TIAB] OR "economics"[MeSH]
1 AND 2 AND 3
"india*"[TIAB] OR "pakistan*"[TIAB] OR
"philippine*"[TIAB] OR "asia*"[TIAB] OR "africa*"[TIAB]
eSH] 4 AND 5
s"[MeSH]
As this review was part of a larger project that evaluates the economic effects
nd “economics”.
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turer (Nestlé) for further material and performed hand
searches in relevant journals with developing countries
issues (such as The Lancet). All references were stored
in an EndNote X4 database (Thomson/ISI ResearchSoft
Berkeley, CA, USA).
Study selection and data extraction
Three reviewers screened titles and abstracts for rele-
vance and assessed potentially relevant studies for inclu-
sion by full text. Teaching sessions were held in advance
to improve conceptual consistency between reviewers.
Disagreements were resolved by consensus meetings. If
data of a specific population were published in several
papers or if follow-up data were presented, we included
each population only once. Using a predefined form,
data were extracted by one reviewer in an Excel database
and checked independently by a second reviewer.
We extracted data on general study information (e.g.
study region; length and completeness of follow up),
study setting (e.g. level of population recruitment),
population details, intervention (e.g. daily amount of for-
tified MN, determined as daily difference between inter-
vention and control group; composition of MN;
comparator food) and outcome (e.g. morbidity rates;
hemoglobin levels [g/dl; conversion to g/L with factor
10]).
One reviewer assessed risk of bias in individual studies
with a component approach exploring methodological
quality on the study level (adequate generation of ran-
dom sequence, concealment of allocation, blinding) as
well as on the outcome level (incomplete outcome data
due to attrition; selective outcome reporting) [12].
Statistical analysis
First, we calculated pooled estimates. For continuous
variables we computed weighted mean differences
(WMD) and 95%-confidence intervals (CI). For example,
for analysis of hemoglobin change we used the mean
change in the intervention and in the control group and
their pooled standard deviation (SD). If the sample size
decreased during the study, we used the lower sample
size at the end of the study. If mean hemoglobin change
per group and SD were not reported, we calculated
change as the difference of baseline and final values for
intervention and control group and applied the SD of
final values [20]. If 95%-CI of mean values were reported
we converted them to SD assuming normal distribution
[21]. To check results for robustness, we also calculated
WMD for final hemoglobin values of both study groups,
as this data was reported more often. Due to consider-
able heterogeneity between trials, we applied a random
effects model [22]. When authors reported only medians
for continuous data (e.g. for ferritin levels), we did notinclude those data in the meta-analysis. For binary data,
we calculated risk ratios and 95%-CI. Heterogeneity be-
tween trials was calculated with I2, that is the percentage
of the total variation in estimated effects that is due to
heterogeneity rather than chance (where values of 25%
are assigned low, 50% moderate and 75% high) [23].
Second, we divided our dataset into pre-specified sub-
groups to explore the influence of possible modifying
factors on the outcome (fortified milk vs. cereal food;
high vs. low/middle-income countries; single- vs. dual/
multi-micronutrient fortification strategy).
Third, we performed a meta-regression analysis
weighted for the inverse of the variance of the outcome
[12]. With this approach we evaluated the unique contri-
bution of other a priori chosen independent factors on
the most often reported outcome (dependent variable:
hemoglobin level; independent variables: hemoglobin
levels before intervention; daily amount of fortified MN;
length of follow-up; completeness of follow-up).
For parametric and non-parametric tests P-values
<0.05 were considered significant. Analyses were per-
formed using the STATA SE 9 software package (Stata-
Corp. 2007. Stata Statistical Software, College Station,
Texas, USA).Results
Description of included studies
Our searches retrieved 1153 potentially relevant studies
(Figure 1). Eighteen RCT[8-10,24-38] (n = 10 fortified
milk; n = 8 fortified cereals) fulfilled inclusion criteria
and were included for our main analysis (Table 2).
These 18 trials comprised 5468 infants and children
from different regions (2 studies from Asia [8,37], 5
studies from Africa [9,33-36]; 5 Studies from South- and
Middle-America [10,27,29,30,38]; 6 Studies from Europe
[24-26,28,31,32]).
Study population sizes varied from n= 33 to n = 1120
participants (median 166; IQR 92 to 361). Most partici-
pants belonged to vulnerable groups and had been
recruited from different settings (8 studies: medical or
community care centers:, 7 studies: low income risk
groups; 2 studies: general population of peri-urban and
rural areas; 1 study: no information given). The most
frequent exclusion criteria were chronic diseases, severe
anemia, severe mal-/under-nutrition, and low birth
weight. Mean age of participants ranged from 6 to
23 months at inclusion (upper age limit was 3 years in
one study [8]) and the sex ratio was well balanced. Mean
hemoglobin values of children at baseline varied between
studies from 9.0 g/dl to 12.6 g/dl (median of study
values: 11.1 g/dl). Follow up periods were generally short
and did not exceed one year (mean follow up:
8.2 months; range: 2.3 to 12).
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Figure 1 Study flow of the systematic review.
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http://www.biomedcentral.com/1471-2458/12/506Fortified milk was prepared with centrally processed
fortified milk powder in most of the studies. Fortified
cereals comprised centrally processed weaning or com-
plementary food, such as fortified porridge, gruel or
weaning rusk to prepare a pap. Iron was the most fre-
quently used MN for fortification (15 of 18 trials), fol-
lowed by zinc (9 trials) and vitamin A (6 trials). Seven
studies used a single-MN fortification strategy (6 studies
with iron only; 1 study with zinc only), two studies a
dual- and 9 studies a multi-micronutrient (MMN) strat-
egy (i.e. 3 or more MN, for example additional fortifica-
tion with vitamin C and E, selenium, copper).Effect on hemoglobin levels
Hemoglobin blood level was the most frequently
reported outcome parameter. Across 13 studies that
tested iron fortification irrespective of other added MN,
the mean increase of hemoglobin compared to the con-
trol group was 0.62 g/dl (95%-CI: 0.34 to 0.89) for chil-
dren fed with fortified milk or cereals (Figure 2).
Heterogeneity was high (I2 = 86%). Comparison of differ-
ent subgroups showed a stronger effect of the iron
MMN fortification approach (n = 8 studies; hemoglobin
increase 0.87 g/dl (95%-CI: 0.57 to 1.16; I2 = 82%)compared to the iron single-fortification strategy (n = 5
studies; hemoglobin increase 0.20 g/dl (95%-CI: -0.05 to
0.45; I2 = 43%). The daily applied iron dosage was similar
for the single-iron approach (median: 6.5 mg) and the
MMN-approach (median 6.7 mg).Effect on anemia prevalence
Eleven trials provided data for anemia rates, all of them
using iron as a single- or a MMN-fortification strategy.
Applied thresholds for anemia varied between 10.5 g/dl
and 11 g/dl and the median of anemia rates at baseline
was 36% (IQR: 15% to 40%; 9 studies with data). Forti-
fied milk or cereals reduced the risk of suffering from
anemia by 50% (risk ratio 0.50, 95%-CI: 0.33 to 0.75;
I2 = 71%; Figure 3). Again, a stronger effect of the MMN
fortification approach emerged (n = 7 studies; risk ratio
0.43 (95%-CI: 0.26 to 0.71; I2 = 81%) compared to the
iron single-fortification strategy (n = 4 studies; risk ratio
0.76 (95%-CI: 0.45 to 1.28; I2 = 0%). Overall, the absolute
risk reduction (ARR) of suffering from anemia was 14%
(un-weighted data of 11 trials), translating into a number
needed to treat (NNT) with fortified milk or cereals of 7
(95%-CI: 6 to 9) participants over a period of 8 months
(i.e. the mean follow-up time) to avoid one case of
Table 2 Details of included studies for fortification of milk and cereal food
Study Population Intervention Control food Outcome Comment
Author, year: Brown,
2007 [29] Design: RCT
Country: Peru Target population:
periurban area; Age (mean; range):
0.6; 0.5 to 0.7 years Males (%): 46
Exclusion criteria: risk of acute
malnutrition; chronic diseases
Cereals, fortified (porridge); single
MN strategy MN applied a: Zn
Iron dosage b: n.a.c mg/day; Iron
compound d: n.a.
porridge,
unfortified
for zink
After 0.5 year: plasma zinc;
anthropometry; infections
Both groups recieved iron
fortification and vitamin
supplements, thus net
intervention was zinc
fortification.
Author, year: Daly,
1996 [31] Design: RCT
Country: UK (74% white; 24%
Afro-Caribbean; 2% Asian) Target
population: poor innerurban Age
(mean; range): 0.65; 0.5 to 0.7
years Males (%): 47 Exclusion
criteria: preterm at birth
Milk, fortified; multi MN strategy
MN applied: Fe, VitA, other
Vitamins, other MN Iron dosage:
5.47 mg/day; Iron compound:
no info
milk,
unfortified
After 1 year: hematological
parameters; anthropometry
Functional outcome was
extracted from related paper
Williams_1999 [39].
Author, year: Faber,
2005 [33] Design: RCT
Country: South Africa Target
population: rural area, low
socio-economic status, Age (mean;
range): 0.7; 0.6 to 0.9 years Males
(%): 51 Exclusion criteria: birth
weight <2500 g, severe anemia
Cereals, fortified (porridge); multi
MN strategy MN applied: Fe, Zn,
other Vitamins Iron dosage: 27.5
mg/day; Iron compound: FeFu
porridge,
unfortified
After 0.5 year: hematological
parameters, serum retinol,
zinc; growth; motor
development
Population baseline
characteristics only for
infants who completed
the study.
Author, year: Gibson,
2011 [35] Design: RCT
Country: Zambia Target population:
middle income class Age (mean;
range): 0.5; 0.5 to 0.5 years Males
(%): 48 Exclusion criteria: "not in
good health"
Cereals, fortified (porridge); multi
MN strategy MN applied: Fe, Zn,
other Vitamins, other MN Iron
dosage: 5.36 mg/day; Iron
compound: no info
porridge,
unfortified
After 1 year: hematological
parameters; serum zink,
anthropometry; hospital
referral; death; diarrhea;
pneumonia; mental and
motor development
All children received VitA and
Iodine by a public
supplementation program.
Some outcomes extracted
from related paper
(Chilenje_2010) [40] and
(Manno_2011) [41].
Author, year: Gill,
1997 [24] Design: RCT
Country: Ireland Target population:
no info Age (mean; range): 0.5; 0.5
to 0.5 years Males (%): 51 Exclusion
criteria: severe or chronic disaese,
malnutrition; congenital anomalies
Milk, fortified; single MN strategy
MN applied: Fe Iron dosage: 6.54
mg/day; Iron compound: FeSu
formula milk,
unfortified
for iron
After 0.75 year:
hematological parameters,
anthropometry
Author, year: Lartey,
1999 [34] Design: RCT
Country: Ghana Target population:
urban area Age (mean; range): 0.5; 0.5
to 0.5 years Males (%): 48 Exclusion
criteria: congenital abnormalities
Cereals, fortified (porridge); multi
MN strategy MN applied: Fe, Zn,
VitA, other Vitamins, other MN
Iron dosage: 14.25 mg/day; Iron
compound: electrFe
porridge,
unfortified
After 0.5 year: hematological
parameters; anthropometry;
diarrhea; fever; respiratory
illness
Intervention cereal with 2
formulations of fortification
depending on daily cereal
intake of infant to avoid
potential toxicity problems.
Author, year: Liu, 1993
[37] Design: RCT
Country: China Target population: all
population classes (90% of all
children) Age (mean; range): 0.8; 0.5
to 1.1 years Males (%): 55 Exclusion
criteria: no info
Cereals, fortified (rusk); multi MN
strategy MN applied: Fe, Zn, VitA,
other Vitamins, other MN Iron
dosage: 5 mg/day; Iron
compound: FeAmCi
rusk,
unfortified
After 0.25 year: hematological
paramters; MN-serum levels,
anthropometry
Author, year: Maldonado
Lonzano, 2007 [25]
Design: RCT
Country: Spain Target population: no
info Age (mean; range): 1.9; (range:
no info) years Males (%): 58 Exclusion
criteria: iron supplementation
Milk, fortified; multi MN strategy
MN applied: Fe, other Vitamins,
other MN Iron dosage: 5.9
mg/day; Iron compound: no info
milk, unfortified
(cows whole
milk formula)
After 0.33 year: hematological
parameters
No child with anemia
at baseline.
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Table 2 Details of included studies for fortification of milk and cereal food (Continued)
Author, year: Morley,
1999 [26] Design: RCT
Country: UK (Indian ethnicity) Target
population: mother with higher
eduction, non-manual social class Age
(mean; range): 0.78; (range: no info)
years Males (%): 50 Exclusion criteria:
relevant disease; iron supplementation
Milk, fortified; single MN strategy
MN applied: Fe Iron dosage: 1.8
mg/day; Iron compound: FeSu
formula,
unfortified
After 0.75 year: hematological
parameters, antropometry,
motor and mental
development
Only data from Norwich cohort
blood samples could be taken at
baseline and were extracted for
Hb outcome.
Author, year: Nesamvuni,
2005 [36] Design: RCT
Country: South Africa Target
population: poor socio-economic
status, undernourished children Age
(mean; range): no info; 1 to 3 years
Males (%): 0 Exclusion criteria: physical
or mental disability, severe
undernutrition
Cereals, fortified (maize porridge);
dual MN strategy MN applied: VitA,
other Vitamins Iron dosage: n.a.
mg/day; Iron compound: n.a.
maize meal,
unfortified
After 1 year: hematological
parameters, retinol level,
anthropometry
Children and family members
received the food.
Author, year: Oelofse,
2003 [9] Design: RCT
Country: South Africa Target population:
urban disadvantaged black community
(low socioeconomic status) Age (mean;
range): 0.5; (range: no info) years Males
(%): 0 Exclusion criteria: birth weight
< 2.5 kg; congenital abnormalities
Cereals, fortified (porridge); dual
MN strategy MN applied: Zn, other
Vitamins Iron dosage: -0.8 mg/day;
Iron compound: FePP
normal diet After 0.5 year: hematological
parameters, zinc level, retinol
level, anthropometry,
psychomotor development
90% of control group already
recieved commercially prepared
complementatry food. The food
concentration of iron did not
relevanlty differ between groups,
but of Zinc and of VitA.
Author, year: Rivera, 2010
[10] Design: RCT (accounted
for cluster randomisation)
Country: Mexico Target population:
households living in poverty Age
(mean; range): no info; 1 to 2.5 years
Males (%): 50 Exclusion criteria: no info
Milk, fortified; multi MN strategy
MN applied: Fe, Zn, other Vitamins,
other MN Iron dosage: 7.82
mg/day; Iron compound: FeGlu
milk,
non-fortified
After 1 year: hematological
parameters
Study results are adjusted for
cluster effect. Evaluation of a
large scale program (Leche
Lincosa) in Mexico.
Author, year: Sazawal, 2010
[8] Design: RCT
Country: India Target population:
periurban area; illiteracy of parents Age
(mean; range): 1.9; 1 to 3 years Males
(%): 50 Exclusion criteria: severe
malnutrition; severe illness
Milk, fortified; multi MN strategy
MN applied: Fe, Zn, VitA, other
Vitamins, other MN Iron dosage:
8.3 mg/day; Iron compound: FeSu
milk,
unfortified
After 1 year: hematological
parameters, anthropometry,
severe illnesses, diarrhoea,
lower respiratory tract
infections, pneumonia
Some data extracted from
relating paper: Sazawal_2006
[42] Completeness relates to
hematologic parameters.
Author, year: Schümann,
2005 [38] Design: RCT
Country: Guatemala Target population:
low income; periurban settlement Age
(mean; range): 1.7; 1 to 2 years Males
(%): 52 Exclusion criteria: gastric or
intestinal diseases; infections
Cereals, fortified (bean paste);
single MN strategy MN applied:
Fe Iron dosage: 17.1 mg/day;
Iron compound: FeSu
beans,
unfortified
After 0.19 year:
hematological parameters
All children recieved anthelmintic
treatment; all families were
compensated. Three arm trial: Only
data for FeSu group (n = 31) vs.
control group (n = 30) extracted.
Author, year: Stevens, 1998
[32] Design: RCT
Country: UK (mostly caucasian) Target
population: lower social classes were
overrepresented Age (mean; range):
0.5; 0 to 0 years Males (%): 0 Exclusion
criteria: illness, major congenital
malformation
Milk, fortified; single MN strategy
MN applied: Fe Iron dosage: 6.87
mg/day; Iron compound: FeSu
milk, unfortified After 1 year:
hematological parameters
Author, year: Villalpando,
2006 [27] Design: RCT
Country: Mexico Target population:
poor periurban community Age (mean;
range): 1.8; 0.8 to 2.5 years Males (%):
50 Exclusion criteria: no info
Milk, fortified; multi MN strategy
MN applied: Fe, Zn, other
Vitamins Iron dosage: 6.74
mg/day; Iron compound: FeGlu
milk, unfortified After 0.5 year:
hematological parameters
The results of the study lead to
broadening of a fortified milk
distribution program in Mexico.
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Table 2 Details of included studies for fortification of milk and cereal food (Continued)
Author, year: Virtanen, 2001
[28] Design: RCT
Country: Sweden Target population:
urban area Age (mean; range): 1; 1 to
1 years Males (%): 39 Exclusion criteria:
milk intolerance; poor health
Milk, fortified; single MN strategy
MN applied: Fe Iron dosage: 4.53
mg/day; Iron compound: FeGlu,
FeLac
milk, unfortified After 0.5 year:
hematological parameters
Author, year: Walter, 1998
[30] Design: RCT
Country: Chile Target population: From
four contiguos urban communities Age
(mean; range): 0.5; 0 to 0 years Males
(%): 52 Exclusion criteria: major birth or
neonatal complications, chronic illness
Milk, fortified; single MN strategy
MN applied: Fe Iron dosage: 6.5
mg/day; Iron compound: FeSu
formula, low
iron fortifed
After 1 year:
hematological parameters,
anthropometry
a MN (micronutrient) applied: Fe: iron; Zn: zinc; VitA: Vitamin A; other Vitamins: e.g. Vitamin C; other MN (micronutirents): e.g. selen, copper.
b Iron dosage: Determined as daily difference between intervention and control group.
c n.a.: not applicable
d Iron compound: FeSu: iron-sulfate; FePP: iron-pyrophosphate; NaFeEDTA: natrium-iron-EDTA; FeFu: iron-fumarate; FeGlu: iron-gluconate; FeAmCi: ferric-ammonium-citrate; FeLa: Ferrous lactate; electrFe: electrolytic
iron.
Eichler
et
al.BM
C
Public
H
ealth
2012,12:506
Page
7
of
13
http://w
w
w
.biom
edcentral.com
/1471-2458/12/506
..
Overall  (I-squared = 86.2%, p = 0.000)
Virtanen (2001)
Liu (1993)
Sazawal (2010)
Gibson (2011)
Subtotal  (I-squared = 81.5%, p = 0.000)
Subtotal  (I-squared = 43.4%, p = 0.132)
Faber (2005)
Villalpando (2006)
Study
Daly (1996)
3
Lartey (1999)
Morley (1999)
Schümann (2005)
Maldonado Lonzano (2007)
ID
Gill (1997)
1
Stevens (1998)
0.62 (0.34, 0.89)
-0.12 (-0.51, 0.27)
0.71 (0.35, 1.07)
1.54 (1.29, 1.79)
0.60 (0.40, 0.80)
0.87 (0.57, 1.16)
0.20 (-0.05, 0.45)
0.90 (0.45, 1.35)
0.92 (0.48, 1.36)
mean difference
0.90 (0.46, 1.34)
0.50 (-0.17, 1.17)
0.30 (-0.21, 0.81)
0.10 (-0.44, 0.64)
0.70 (0.26, 1.14)
Hb [g/dl] (95% CI)
0.15 (-0.13, 0.43)
0.67 (0.21, 1.13)
1201
20, .14 (.67)
77, -.08 (1.23)
233, 1.98 (1.14)
278, .5 (1.1)
894
307
144, .8 (1.22)
58, .91 (1.15)
N, mean (SD);
41, .4 (.7)
47, 0 (1.4)
40, 2.7 (1.1)
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Fortification
192, .26 (.92)
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Figure 2 Effect of iron fortification of milk and cereals on hemoglobin (Hb) levels compared to non-fortified food. Only studies with iron
fortification included (n = 13 RCT). Results are provided as weighted mean difference in hemoglobin (WMD: g/dl with 95%-CI; conversion to g/L
with factor 10) between intervention and control group (iron single-fortification (1); iron multi micronutrient fortification (3); overall effect).
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http://www.biomedcentral.com/1471-2458/12/506anemia. For the MMN approach these results are even
more favorable (un-weighted data of 7 trials: ARR 22%;
NNT 5 [95%-CI: 4 to 6]).Effect on ferritin levels
Ferritin is the most direct measure to conclude if iron
stores increase by iron-fortified food consumption.
Eleven trials provided data for ferritin serum levels. Fer-
ritin levels were not adjusted for subclinical infections.
Given the skewed distribution of ferritin values, authors
often reported median estimates. Medians were signifi-
cantly higher in the intervention groups (ranges of fer-
ritin medians at end of study [micro-g/l]: intervention:
15.8 to 44.6; control: 6.5 to 28; P< 0.01). Only three
studies provided mean values to be included in a meta-
analysis, which showed an effect in the same direction.
The mean ferritin increase with iron fortification was
11.3 micro-g/l (95%-CI: 3.3 to 19.2; I2 = 79%) compared
to control groups.Effects on serum zinc and vitamin A levels
Five studies provided data for change in serum zinc
levels. MN fortification with zinc led to no relevant
change in zinc serum levels (0.4 micro-g/dl (95%-CI: -1
.7 to 2.6; I2 = 0%) compared to control groups. However,
fortification increased vitamin A serum levels compared
to control groups (four studies with data: Retinol in-
crease by 3.7 micro-g/dl [95%-CI: 1.3 to 6.1; I2 = 37%]).
Effects on growth, functional measures and morbidity
For three European studies, no relevant effect of fortifi-
cation on height and weight was seen and morbidities
were not an issue in this population.
All other results relate to non-European low-/middle
income countries. Due to the short follow-up period in
most of the studies, no meaningful conclusion can be
drawn for possible effects of fortification on height or
weight gain or z-scores (weight-for-age; height-for-age;
weight-for-height). Of 9 studies with data, 7 trials
reported no relevant differences between intervention
..
Overall  (I-squared = 71.2%, p = 0.000)
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3
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Risk Ratio for
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Figure 3 Effect of iron fortification of milk and cereals on anemia compared to non-fortified food. Only studies with iron fortification
included (n = 11 RCT). Results are provided as risk ratio (RR, 95%-CI) of suffering from anemia in the intervention group compared to the control
group (iron single-fortification (1); iron multi micronutrient fortification (3); overall effect).
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http://www.biomedcentral.com/1471-2458/12/506and control group at the end of the study. In one study
[36], more weight gain was seen in the intervention
group after one year (4.6 kg vs. 2.0 kg; P< 0.05), in an-
other study [8] children consuming fortified milk
showed improvement in weight gain compared to con-
trol group (difference 0.21 kg/year [95%-CI 0.12 to 0.31)
and height gain (difference 0.51 cm/year [95%-CI 0.27 to
0.75).
Of three studies with data for psychomotor develop-
ment of children, two trials reported no relevant differ-
ence between groups [9,35] and one study [33] found
slight improvements compared to the control group.
Of four studies with morbidity data of children, three
trials reported no relevant differences between groups
for infections [29], for diarrhea, fever and respiratory ill-
ness [34] and for referral to hospital or death in partly
HIV exposed children [35]. In one study [8] fortifiedmilk significantly reduced the probability of days with
severe illness (by 15%), and the relative risk of diarrhea
(by 18%) and lower respiratory illness (by 26%).Exploring heterogeneity
In our pre-specified subgroup analyses no relevant influ-
ence on the outcome was detected for the mode of forti-
fied food (fortified milk vs. cereals). Hemoglobin change
was somewhat higher in studies from low/middle in-
come countries (0.78 g/dl (95%-CI: 0.41 to 1.15) com-
pared to high income countries (0.42 g/dl (95%-CI: 0.10
to 0.73), but the difference was not statistically signifi-
cant. The dual-/multi-micronutrient approach led to a
significantly stronger effect of iron fortification on
hemoglobin increase than the iron single-fortification
strategy (Figure 3).
Table 3 Risk of bias summary table
EN Author Year Adequate
sequence
generation?
Allocation
concealment?
Blinding? Incomplete
outcome
data addressed
Are typical outcomers
reported? (Selective
outcome reporting)
675 Brown 2007 ? ? YES YES YES
818 Daly 1996 ? ? ? YES YES
951 Faber 2005 NO NO` YES NO YES
1058 Gibson 2011 ? ? YES NO YES
153 Gill 1997 ? YES NO NO YES
1051 Lartey 1999 ? YES NO YES YES
1154 Liu 1993 ? ? ? NO YES
257 Maldonado Lonzano 2007 YES YES YES YES NO
282 Morley 1999 ? YES YES YES YES
1149 Nesamvuni 2005 NO NO YES YES YES
297 Oelofse 2003 NO NO NO NO YES
333 Rivera 2010 ? ? YES NO NO
1 Sazawal 2010 YES YES YES NO YES
1172.2 Schumann 2005 NO NO YES YES NO
838 Stevens 1998 ? ? YES NO NO
403 Villalpando 2006 ? ? YES YES NO
404 Virtanen 2001 ? ? YES NO NO
797 Walter 1998 NO YES YES NO YES
The table presents each study by assessed methodological criterion in a cross-tabulation a. Studies are sorted for author name.
a Assessment categories: YES: criterion fulfilled; NO: criterion not fulfilled; “?”: unclear, as no information given.
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http://www.biomedcentral.com/1471-2458/12/506In our multivariable meta-regression analysis, none of
the tested independent variables (mean hemoglobin level
before intervention; daily amount of consumed iron,
length of follow-up, completeness of follow up) was sig-
nificantly associated with the change in hemoglobin.Summary assessment of risk of bias
Only two [8,25] of 18 trials provided enough information
to conclude that both random sequence generation and
allocation concealment was adequately performed
(Table 3). For 11 trials this was unclear and inadequate
procedures had been applied in 5 trials. Other criteria
were fulfilled more often: Blinding was reported in 13 of
18 studies, incomplete outcome data were addressed in
8 of 18 trials and 12 of 18 studies showed no selective
outcome reporting (i.e. besides serum markers also
height/weight, functional measures or morbidities were
reported).
In summary, the risk of bias for the most often
reported outcomes hemoglobin change and anemia rates
is unclear. However, a sensitivity analysis including only
studies with low risk of bias led to similar results (three
studies that fulfilled 4 of 5 quality criteria [8,25,26]:
hemoglobin increase 0.87 g/dl (95%-CI: 0.09 to 1.65;
I2 = 92%). Another sensitivity analysis showed that the
result pattern remained basically unchanged afterperforming analyses using mean values of groups at the
end of the study, instead of mean changes of groups.
Discussion
To our knowledge, this is the first systematic review,
that has applied a meta-analysis to specifically weigh the
overall evidence for the effects of fortified milk and
cereal food suitable for complementary feeding of chil-
dren. The evidence relates to study populations between
6 month and three years of age. Iron fortification leads
to a clinically relevant increase in hemoglobin levels and
reduction of anemia rates. For zinc and vitamin A fortifi-
cation only surrogate parameters are reported, but the
combination with iron (MMN approach) leads to a more
pronounced effect on hemoglobin levels compared to an
iron single-fortification strategy. The evidence for func-
tional health outcomes is inconclusive.
Strengths and limitations
We applied a thorough search strategy with a stepwise
retrieval of studies using electronic databases and add-
itional sources. We cannot exclude having missed refer-
ences but we believe that we found a near complete
sample of relevant papers for our specific research
question.
Some limitations have to be mentioned. First, included
studies showed short follow-up periods, thus the impact
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http://www.biomedcentral.com/1471-2458/12/506of fortified milk or cereal food on functional health out-
comes (such as sustainable height and weight gain or
mental and motor development) could not be assessed
thoroughly. Second, for zinc and vitamin A fortification
only surrogate outcomes as serum levels are available.
However, the presence of additional fortified micronutri-
ents seems to be important for the effects of iron on
hemoglobin levels. The MMN approach is more effective
than iron single fortification in our review, reflecting
that complex micronutrient deficiencies are responsible
for health problems [20]. Third, risk of bias is unclear
mainly due to underreporting of the randomization pro-
cedure and incomplete outcome data. Finally, pooled
estimates have to be interpreted cautiously as statistical
heterogeneity between studies was considerable and
meta-regression did not reveal significant associations of
pre-specified study characteristics with study results.
Possible sources for unexplained heterogeneity might be
underreporting for co-interventions (e.g. public supple-
mentation or food programs) or the diversity of applied
MN preparations that have influence on MN absorption.
For example, five different iron compounds were used
(12 studies with data: six times FeSulfate; twice FeGluco-
nate; one time, each, FePyrophosphate; FeFumarate; Fer-
ric ammonium citrate; electrolytic iron). In addition, the
difference in daily consumed iron between intervention
and control group varied between 1.8 mg and 14.3 mg.
Furthermore, molar ratios, a determinant for MN ab-
sorption, also showed variation (ranges of molar ratios:
ascorbic acid/iron: 0.68 to 30; phytic acid/iron: 1.7 to
2.2; calcium/iron: 40 to 134).
Existing systematic reviews and research needs
Important contributions have been made in the recent
years with other systematic reviews to evaluate the
health effects of MN interventions. These reviews differ
from ours: Dewey and Adu-Afarwuah gave a broad sys-
tematic overview of studies and programs aimed at im-
proving biochemical and functional outcomes with
complementary foods. [43] However, they did not per-
form a meta-analysis and presented results in a tabulated
form or as averaged effect sizes. Some reviews have con-
centrated on MN supplementation only [44-48] or home
fortification [49], other reviews have combined supple-
mentation and fortification strategies for analysis [20,50],
included children as well as adolescents or adult women
[6,51,52], or included fortified staple food interventions
[6,52].
The health effects found in our review are in line with
effect sizes shown in some similar reviews above
[20,47,52]. This underpins the validity of our findings
and supports a strategy to intervene with fortified milk
and cereal food for infants and children. Supplementa-
tion trials, for example with vitamin A, have been shownto reduce mortality and morbidity via improved nutri-
tional status [47,48], even though serum level increases
were small [53], similar to our review. Thus, some
authors conclude that fortification would also have an
impact on morbidity and mortality, although a conclu-
sive answer cannot yet be given [52]. On the other hand,
negative aspects of iron supplementation have been
reported, such as increased morbidity and mortality in
regions where malaria transmission is intense. [54] Thus,
recommendations concerning iron supplementation
have been formulated. [55] These adverse effects, how-
ever, may not be that relevant for fortified foods. Daily
micronutrient dosages of fortified foods are much lower
as compared to supplementation. Furthermore, children
stop eating once they get saturated, which may also not
be the case for high dosage sprinkles, that can be seen as
a specific application of supplementation. Nevertheless,
long term data concerning negative effects of iron forti-
fied foods in regions with high prevalence of malaria and
infectious diseases are lacking.
Further compiled evidence is needed to agree on the
optimal MN preparation for fortified milk and cereals
(such as composition of MN; suitable compounds; molar
ratios for additives) to fully exhaust the potential of this
approach. Future studies should also focus on health
outcomes of MN fortification beyond the effect of iron
on hematological results, for example via long-term
follow-up of study populations.
Implications for decision makers
There are multiple delivery mechanisms for fortified
milk and cereal food. Production and distribution via
government programs and local public agencies would
be an obvious option to strengthen local structures. Im-
plementation of effective strategies, however, does not
always work well in the field due to logistical problems
or inappropriate priority setting [56]. Thus, some have
discussed the role of the business community in improv-
ing nutrition in developing countries [56-58]. Commer-
cially distributed fortified foods (e.g. with iron) are
already available in many markets, even in low-income
countries. In a public private partnership, business part-
ners can provide their professional knowledge and ex-
perience concerning technical problems with processing
and fortification, supply and transport, or refrigeration
and conservation issues (specifically important for milk)
to get interventions more efficient.
A limitation of the market approach is that it may not
reach the poorest of the poor. Thus, a combination of dif-
ferent delivery channels, as well as affordable prices, may
be needed. Children with severe anemia, who may be
overrepresented in very poor groups, are often excluded
from trials due to ethical reasons. One may assume, that
the positive effects on the hemoglobin levels may be even
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http://www.biomedcentral.com/1471-2458/12/506stronger for such children. Additional economic analyses
are necessary to contribute to a deeper understanding of
the health economic effects of such a strategy and to in-
form the priority setting of decision makers.
Conclusions
Multi micronutrient fortified milk and cereal products
can be an effective option to reduce anemia of children
up to three years of age in developing countries. On the
basis of our data the evidence for functional health out-
comes is still inconclusive.
Abbreviations
Fe: Iron; MN: Micro nutrients; MMN: Multi micro nutrients; RCT: Randomized
controlled trial; WMD: Weighted mean difference.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KE designed and conducted research, analyzed data and drafted the
manuscript. SW helped to design research, conducted research, helped to
draft the manuscript. IR conducted research, helped to draft the manuscript.
UB helped to design research, helped to draft the manuscript. All authors
read and approved the final manuscript.
Expert and Affiliation
Lindsay H. Allen - Western Human Nutrition Research Center, USA; Narendra
K. Arora - International Clinical Epidemiology Network, INCLEN, India; Zulfiqar
A. Bhutta - Aga Khan University, Pakistan; Rodolfo F. Florentino - Nutrition
Foundation of the Philippines; Guillermo Meléndez - Mexican Health
Foundation, Mexico; Noel W. Solomons - Program Director for Central
America, International Nutrition Foundation, Guatemala; Edgar Vasquez-
Garibay - University of Guadalajara, Mexico.
Acknowledgements
Thanks also to Richard Hurrell (Swiss Federal Institute of Technology,
Switzerland) and Monika Potter (Dietitian) who provided valuable advice.
Thanks to Paul Kelly for English language editing.
The study was supported by the Nestlé Nutrition Institute. The supporting
source had no influence on study design; in the collection, analysis, and
interpretation of the data; in the writing of the manuscript; and in the
decision to submit the manuscript for publication.
Received: 9 February 2012 Accepted: 6 July 2012
Published: 6 July 2012
References
1. Horton S: Alderman H. Rivera JA: Hunger and Malnutrition. Copenhagen
Consensus Challenge Paper. Copenhagen Consensus Center; 2008.
2. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, Mathers C,
Rivera J: Maternal and child undernutrition: global and regional
exposures and health consequences. Lancet 2008, 371(9608):243–260.
3. Dewey KG, Begum K: Long-term consequences of stunting in early life.
Matern Child Nutr 2011, 7(Suppl 3):5–18.
4. Word Health Organisation: Conclusions and recommendations of the
WHO consultation on prevention and control of iron deficiency in
infants and young children in malaria-endemic areas. Food and Nutrition
Bulletin 2007, 28(4):S621–S631.
5. Allen L, de Benoist B: Dary O. Hurrel R: Guidelines on food fortification with
micronutritients. Edited by WHO Food and Agricultural Organization of the
United Nations. Geneva; 2006.
6. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA,
Kirkwood B, Morris SS, Sachdev HP, et al: What works? Interventions for
maternal and child undernutrition and survival. Lancet 2008,
371(9610):417–440.
7. World Health Assembly Resolution: Infant and young child nutrition. In
WHA Resolution 2001, 542.8. Sazawal S, Dhingra U, Dhingra P, Hiremath G, Sarkar A, Dutta A, Menon VP,
Black RE: Micronutrient fortified milk improves iron status, anemia and
growth among children 1–4 years: a double masked, randomized,
controlled trial. PLoS One 2010, 5(8):e12167.
9. Oelofse A, Van Raaij JM, Benade AJ, Dhansay MA, Tolboom JJ, Hautvast JG:
The effect of a micronutrient-fortified complementary food on
micronutrient status, growth and development of 6- to 12-month-old
disadvantaged urban South African infants. Int J Food Sci Nutr 2003,
54(5):399–407.
10. Rivera JA, Shamah T, Villalpando S, Monterrubio E: Effectiveness of a large-
scale iron-fortified milk distribution program on anemia and iron
deficiency in low-income young children in Mexico. Am J Clin Nutr 2010,
91(2):431–439.
11. NHS Centre for Reviews and Dissemination: CRD’s guidance for undertaking
reviews in health care. York: University of York; 2008.
12. Higgins JP, Green S: Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0 [updated March 2011]. The Cochrane
Collaboration 2011.
13. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. Ann Intern
Med 2009, 151(4):264–269.
14. Heird WC: Progress in promoting breast-feeding, combating
malnutrition, and composition and use of infant formula, 1981–2006.
J Nutr 2007, 137(2):499S–502S.
15. Food and Agricultural Organization of the United Nations: Standard for
infant formula and formulas for special medical purposes intended for
infants. In CODEX STAN 2007, :72–1981.
16. International Clinical Epidemiology Network: http://www.inclentrust.org/.
17. Global Alliance for Improved Nutrition; http://www.gainhealth.org/.
18. The Micronutrient Initiative; http://www.micronutrient.org/english/view.asp?
x=1.
19. Bill & Melinda Gates Foundation; http://www.gatesfoundation.org/Pages/
home.aspx.
20. Allen LH, Peerson JM, Olney DK: Provision of multiple rather than two or
fewer micronutrients more effectively improves growth and other
outcomes in micronutrient-deficient children and adults. J Nutr 2009,
139(5):1022–1030.
21. Altman DG, Machin D, Bryant TN, Gardner JM: Statistics with confidence.
Bristol: BMJ Books; 2001.
22. Khan KS, Kunz R, Kleijnen J, Antes G: Systematic reviews to support evidence-
based medicine. London: Royal Society of Medicine Press; 2003.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency
in meta-analyses. BMJ 2003, 327(7414):557–560.
24. Gill DG, Vincent S, Segal DS: Follow-on formula in the prevention of iron
deficiency: a multicentre study. Acta Paediatr 1997, 86(7):683–689.
25. Maldonado Lozano J, Baro L, Ramirez-Tortosa MC, Gil F, Linde J, Lopez-
Huertas E, Boza JJ, Gil A: Intake of an iron-supplemented milk formula as
a preventive measure to avoid low iron status in 1–3 year-olds. An
Pediatr (Barc) 2007, 66(6):591–596.
26. Morley R, Abbott R, Fairweather-Tait S, MacFadyen U, Stephenson T, Lucas
A: Iron fortified follow on formula from 9 to 18 months improves iron
status but not development or growth: a randomised trial. Arch Dis Child
1999, 81(3):247–252.
27. Villalpando S, Shamah T, Rivera JA, Lara Y, Monterrubio E: Fortifying milk
with ferrous gluconate and zinc oxide in a public nutrition program
reduced the prevalence of anemia in toddlers. J Nutr 2006,
136(10):2633–2637.
28. Virtanen MA, Svahn CJ, Viinikka LU, Raiha NC, Siimes MA, Axelsson IE: Iron-
fortified and unfortified cow's milk: effects on iron intakes and iron
status in young children. Acta Paediatr 2001, 90(7):724–731.
29. Brown KH, López de Romaña D, Arsenault JE, Peerson JM, Penny ME:
Comparison of the effects of zinc delivered in a fortified food or a
liquid supplement on the growth, morbidity, and plasma zinc
concentrations of young Peruvian children. Am J Clin Nutr 2007,
2:538–547.
30. Walter T, Pino P, Pizarro F, Lozoff B: Prevention of iron-deficiency anemia:
comparison of high- and low-iron formulas in term healthy infants after six
months of life. J Pediatr 1998, 4:635–640.
31. Daly A, MacDonald A, Aukett A, Williams J, Wolf A, Davidson J, Booth IW:
Prevention of anaemia in inner city toddlers by an iron supplemented cows'
milk formula. Arch Dis Child 1996, 1:9–16.
Eichler et al. BMC Public Health 2012, 12:506 Page 13 of 13
http://www.biomedcentral.com/1471-2458/12/50632. Stevens D, Nelson A: The effect of iron in formula milk after 6 months of
age. Arch Dis Child 1995, 3:216–220.
33. Faber M, Kvalsvig JD, Lombard CJ, Benadé AJ: Effect of a fortified maize-
meal porridge on anemia, micronutrient status, and motor development
of infants. Am J Clin Nutr 2005, 5:1032–1039.
34. Lartey A, Manu A, Brown KH, Peerson JM, Dewey KG: A randomized,
community-based trial of the effects of improved, centrally processed
complementary foods on growth and micronutrient status of Ghanaian
infants from 6 to 12 mo of age. Am J Clin Nutr 1999, 70(3):391–404.
35. Gibson RS, Kafwembe E, Mwanza S, Gosset L, Bailey KB, Mullen A, Baisley K,
Filteau S: A Micronutrient-Fortified Food Enhances Iron and Selenium
Status of Zambian Infants but Has Limited Efficacy on Zinc. J Nutr 2011,
141:935–943.
36. Nesamvuni AE, Vorster HH, Margetts BM, Kruger A: Fortification of maize
meal improved the nutritional status of 1-3-year-old African children.
Public Health Nutr 2005, 8(5):461–467.
37. Liu DS, Bates CJ, Yin TA, Wang XB, Lu CQ: Nutritional efficacy of a fortified
weaning rusk in a rural area near Beijing. Am J Clin Nutr 1993,
57(4):506–511.
38. Schumann K, Romero-Abal ME, Maurer A, Luck T, Beard J, Murray-Kolb L,
Bulux J, Mena I, Solomons NW: Haematological response to haem iron or
ferrous sulphate mixed with refried black beans in moderately anaemic
Guatemalan pre-school children. Public Health Nutr 2005, 8(6):572–581.
39. Williams J, Wolff A, Daly A, MacDonald A, Aukett A, Booth IW: Iron
supplemented formula milk related to reduction in psychomotor decline
in infants from inner city areas: randomised study. BMJ 1999,
318(7185):693–697.
40. Chilenje Infant Growth Nutrition Infection Study Team: Micronutrient
fortification to improve growth and health of maternally HIV-unexposed
and exposed Zambian infants: a randomised controlled trial. PloS one
2010, 6:e11165.
41. Manno D, Kowa PK, Bwalya HK, Siame J, Grantham-McGregor S, Baisley K,
De Stavola BL, Jaffar S, Filteau S: Rich micronutrient fortification of locally
produced infant food does not improve mental and motor development
of Zambian infants: a randomised controlled trial. Br J Nutr 2011, :1–11.
doi:10.1017/S0007114511003217.
42. Sazawal S, Dhingra U, Dhingra P, Hiremath G, Kumar J, Sarkar A, Menon VP,
Black RE: Effects of fortified milk on morbidity in young children in north
India: community based, randomised, double masked placebo
controlled trial. BMJ 2007, 334(7585):140.
43. Dewey KG, Adu-Afarwuah S: Systematic review of the efficacy and
effectiveness of complementary feeding interventions in developing
countries. Matern Child Nutr 2008, 4(Suppl 1):24–85.
44. Gera T, Sachdev HP, Nestel P, Sachdev SS: Effect of iron supplementation
on haemoglobin response in children: systematic review of randomised
controlled trials. J Pediatr Gastroenterol Nutr 2007, 44(4):468–486.
45. Ojukwu JU, Okebe JU, Yahav D, Paul M: Oral iron supplementation for
preventing or treating anaemia among children in malaria-endemic
areas. Cochrane Database Syst Rev 2009, 3. CD006589.
46. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A, Khatun F,
Martorell R, Ninh NX, Penny ME, et al: Prevention of diarrhea and
pneumonia by zinc supplementation in children in developing countries:
pooled analysis of randomized controlled trials. Zinc Investigators'
Collaborative Group. J Pediatr 1999, 135(6):689–697.
47. Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA: Vitamin A
supplements for preventing mortality, illness, and blindness in children
aged under 5: systematic review and meta-analysis. BMJ 2011, 343:d5094.
48. Haider Batool A, Bhutta Zulfiqar A: Neonatal vitamin A supplementation
for the prevention of mortality and morbidity in term neonates in
developing countries (Review). Cochrane Library 2011, 10:CD006980.
49. De-Regil LM, Suchdev PS, Vist GE, Walleser S, Pena-Rosas JP: Home
fortification of foods with multiple micronutrient powders for health and
nutrition in children under two years of age. Cochrane Database Syst Rev
2010, 12:CD008524. CD006980.
50. Ramakrishnan U, Aburto N, McCabe G, Martorell R: Multimicronutrient
interventions but not vitamin a or iron interventions alone improve
child growth: results of 3 meta-analyses. J Nutr 2004, 134(10):2592–2602.
51. Hess SY, Brown KH: Impact of zinc fortification on zinc nutrition. Food
Nutr Bull 2009, 30(1):79–107.
52. Bhutta Zulfiqar A, Das JK, Dean SV, Salam RA: Effectiveness of Food
Fortification with Micronutrients. A Review. Geneva: Nestle; 2012.53. Imdad A, Herzer K, Mayo-Wilson E, Yakoob M, Bhutta Z: Vitamin A
supplementation for preventiing morbidity and mortality in children six
months to five years of age. Cochrane Database of Systematic Reviews
2010, 5.
54. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra
U, Kabole I, Deb S, Othman MK, et al: Effects of routine prophylactic
supplementation with iron and folic acid on admission to hospital and
mortality in preschool children in a high malaria transmission setting:
community-based, randomised, placebo-controlled trial. Lancet 2006,
367(9505):133–143.
55. World Health Organisation: Iron supplementation of young children in regions
where malaria transmission is intense and infectious disease higly prevalent.
Geneva: World Health Organisation; 2007.
56. Bryce J, Coitinho D, Darnton-Hill I, Pelletier D, Pinstrup-Andersen P:
Maternal and child undernutrition: effective action at national level.
Lancet 2008, 371(9611):510–526.
57. Darnton-Hill I, Nalubola R: Fortification strategies to meet micronutrient
needs: successes and failures. Proc Nutr Soc 2002, 61(2):231–241.
58. Scaling up Nutrition: Road Map Implementation; www.unscn.org/
sacling_up_nutrition_sun/.
doi:10.1186/1471-2458-12-506
Cite this article as: Eichler et al.: Effects of micronutrient fortified milk
and cereal food for infants and children: a systematic review. BMC Public
Health 2012 12:506.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
